Free Trial

Unity Biotechnology (UBX) SEC Filings & 10K Form

Unity Biotechnology logo
$2.22 +0.08 (+3.74%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$2.27 +0.05 (+2.30%)
As of 01/31/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Unity Biotechnology SEC Filings

DateFilerForm TypeView
01/23/2025
3:07 PM
Nguyen Alexander Hieu (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:03 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Sullivan Lynne Marie (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:35 PM
Grossi Federico (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:30 PM
Grossi Federico (Reporting)
Unity Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2025
7:00 AM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Nguyen Alexander Hieu (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
3:10 PM
Sullivan Lynne Marie (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
3:10 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:30 PM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:31 PM
Unity Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/26/2024
3:05 PM
Sullivan Lynne Marie (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:05 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:05 PM
Nguyen Alexander Hieu (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
Samar Michael P. (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
O'Neill Gilmore Neil (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
Leonard Keith R (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
David Nathaniel E (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
BERNS PAUL L (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
Roberts Margo R (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
Samuels Camille D (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:05 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:20 PM
Unity Biotechnology (Filer)
Form ARS
04/26/2024
3:15 PM
Unity Biotechnology (Filer)
Form DEFA14A
04/15/2024
8:10 AM
Unity Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/15/2024
7:51 AM
Unity Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
6:00 AM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:00 AM
Unity Biotechnology (Filer)
Form NT 10-K
03/20/2024
3:15 PM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:05 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:UBX) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners